- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Call
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Mark Eaton
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marco Herold
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sant-Rayn Pasricha
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A new regulator of 'stemness' to create dendritic cell factories for immunotherapy
- Advanced imaging interrogation of pathogen induced NETosis
- Cancer driver deserts
- Cryo-electron microscopy of Wnt signalling complexes
- Deciphering the heterogeneity of breast cancer at the epigenetic and genetic levels
- Developing drugs to block malaria transmission
- Developing new computational tools for CRISPR genomics to advance cancer research
- Developing novel antibody-based methods for regulating apoptotic cell death
- Discovering novel paradigms to cure viral and bacterial infections
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Do membrane forces govern assembly of the deadly apoptotic pore?
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- E3 ubiquitin ligases in neurodegeneration, autoinflammation and cancer
- Engineering improved CAR-T cell therapies
- Epigenetic biomarkers of tuberculosis infection
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- Genomic rearrangement detection with third generation sequencing technology
- How does DNA damage shape disease susceptibility over a lifetime?
- How does DNA hypermutation shape the development of solid tumours?
- How platelets prevent neonatal stroke
- Human lung protective immunity to tuberculosis
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of dysregulated Tom40 in neurodegeneration
- Investigating the role of mutant p53 in cancer
- Lupus: proteasome inhibitors and inflammation
- Machine learning methods for somatic genome rearrangement detection
- Malaria: going bananas for sex
- Measurements of malaria parasite and erythrocyte membrane interactions using cutting-edge microscopy
- Measuring susceptibility of cancer cells to BH3-mimetics
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Mutational signatures of structural variation
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Revealing the epigenetic origins of immune disease
- Reversing antimalarial resistance in human malaria parasites
- Structural and functional analysis of DNA repair complexes
- Targeting human infective coronaviruses using alpaca antibodies
- Towards targeting altered glial biology in high-grade brain cancers
- Uncovering the real impact of persistent malaria infections
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding how malaria parasites sabotage acquisition of immunity
- Understanding malaria infection dynamics
- Understanding the mechanism of type I cytokine receptor activation
- Unveiling the heterogeneity of small cell lung cancer
- Using alpaca antibodies to understand malaria invasion and transmission
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to cross the blood brain barrier for drug delivery
- Using structural biology to understand programmed cell death
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Infection

Infections from viruses, bacteria, fungi and parasites are significant causes of worldwide illness and death.
Our researchers investigate many significant infectious agents with the goal of reducing the global burden of infectious disease.
Our infectious disease research
Our researchers are working to develop better ways to prevent, diagnose and treat infectious diseases. Infections we study include:
- Viral diseases, such as hepatitis B, HIV and influenza.
- Bacterial diseases, such as tuberculosis.
- Fungal diseases, such as cryptococcosis.
- Parasitic diseases, such as malaria, toxoplasmosis and scabies.
Our research into particular infectious diseases is closely integrated with investigations into how our immune system responds to that disease. This is contributing to:
- Advancing vaccine development to generate immune responses that prevent infections.
- New strategies to treat infections through manipulating our immune response.
What are infections?
We are constantly exposed to many different types of living organisms in our environment. A small proportion of these are able to invade our body and live within us. When an invading organism makes us sick, this is termed an infection.
In some cases, organisms living within us are beneficial to our health. For example, many bacteria living in our bowel are important for digestion and are a source of certain vitamins. These ‘friendly’ organisms can also impede the entry of disease-causing infectious organisms.
Types of infectious organisms
A diversity of living organisms has developed the ability to live within our bodies. The broad classes of these include:
- Viruses, small particles that enclose a viral genome that must reproduce within cells.
- Bacteria, simple cells that can often divide rapidly.
- Fungi, more complex cells or branching strands of cells.
- Parasites, a broad term for organisms that invade our body that are not any of the above classes. They can include single-cell ‘protists’, and parasitic animals such as parasitic worms, and parasitic mites.
Organisms that are only visible using a microscope, such as viruses, bacteria and many fungi and single cell parasites, are often called ‘microbes’.
Infections can occur in many different parts of our body. Some organisms, such as the scabies mite, invade only a few millimetres into the outer layers of our skin. Viruses can only grow and reproduce within cells.
Some bacteria, fungi and parasites also grow within cells. Others can live within certain tissues in our body, or in cavities such as our lungs or mouth. Some diseases can occur without direct contact with the microbe, such as illness caused by toxins released by bacteria into foods.
How do infections make us sick?
There are many different ways that infectious agents make us sick. These include:
- Damaging cells or tissues within our body directly, such as a virus killing its host cell.
- Secreting toxins that damage cells.
- Forcing cells to behave abnormally, such as dividing uncontrollably.
- Competing for nutrients or other resources with our own cells.
- Physically obstructing the normal function of an organ.
- Triggering harmful immune responses or inflammation.
The immune response is critical to prevent infections spreading. People with immunodeficiencies may not mount an appropriate immune response and can suffer overwhelming illness from microbes that normally cause mild or no infection.
The symptoms of an infection can be caused by:
- The infectious agent itself, or toxins it releases.
- The immune response to that infection, especially inflammatory responses
The duration of an infection can vary. An infection can be:
- Acute, meaning the infectious agent is soon removed, although the damage it causes may take longer to resolve.
- Chronic, meaning the infectious organism persists within our body long-term, avoiding immune clearance.
Some infections are chronic, but periodically reappear in an acute form.
Evading the immune system
Our immune system protects us from many infections. However, some infectious organisms have developed strategies to evade our immune defenses. These can include:
- Changing proteins on their surface (or the surface of an infected cell) to evade specific immune responses.
- Hiding within cells.
- Producing a dormant form that can re-awaken when host immunity is weakened.
- Residing in parts of the body that are poorly accessed by the immune system, such as the skin surface or brain.
Our researchers are discovering how particular infectious organisms evade immune detection. This is revealing new strategies for enhancing the immune response to clear the infection, and also new approaches to designing vaccines to prevent infection.
How are infections prevented?
Two important ways to prevent contacting an infectious disease are:
- Avoiding exposure to the infectious agent, such as avoiding mosquito bites to prevent malaria, and washing hands to reduce the spread of influenza.
- Inducing a protective immune response, such as through vaccination, that prevents the infection establishing.
The smallpox virus was the first infection to be completely eliminated from humans worldwide, aided by a global vaccination program. Our researchers aspire to contribute to the elimination of other infections, particularly malaria.
How are infections treated?
The ideal treatments for infections kill the infectious agent without harming the body’s own cells. Many treatments target molecular differences between microbes and humans.
The broad classes of medicines used to treat infections are:
- Antivirals
- Antibiotics, to treat bacterial infections
- Antifungals
- Antiparasitics
Our researchers are investigating many new approaches to treating disease. An important focus is to identify molecules unique to an infectious agent that can be targeted by new medicines developed using medicinal chemistry.
Our researchers are also developing new approaches to treating infections, particularly chronic infections, by boosting the immune response to the infectious agent.
For some infectious diseases, treatments also involve reversing or resolving the damage caused by the infection. For example, people with gastrointestinal infections who are dehydrated are given additional fluids.
Drug resistance
As infectious organisms proliferate, some acquire genetic changes. Occasionally these allow an organism to become resistant to a particular treatment. When that treatment is given, the resistant microbes can continue to grow in our bodies, replacing the treatment-sensitive organisms. Resistance is more likely to develop when people do not take a full course of treatment, such as an antibiotic course.
Over time a drug-resistant strain of a disease can become the predominant strain in the community. When more than one type of treatment for an infection is available, a strain of microbes resistant to one treatment may be sensitive to another.
Over time, multi-drug resistance can develop, rendering many treatments ineffective. Increasing rates of multi-drug resistance are limiting the options for treating many types of infection, including malaria and tuberculosis.
Our researchers aim to develop new treatments for infections using approaches that minimise the likelihood of resistance developing. By investigating the basic biology of infections, they are revealing how drug resistance occurs, and designing treatment strategies that are more difficult to evade.
Treatments that boost the immune system’s clearance of infections are another approach that may overcome problems posed by multidrug resistant infections.
Researchers:
The institute's malaria research team is homing in on a new target for malaria treatment
Visualisation of the parasite infection inside a pregnant female mosquito.
Professor Marc Pellegrini discusses the threat of antibiotic resistant bacteria.
International health officials recently warned of a “catastrophic threat” to human health, given one of the last remaining antibiotics capable of defeating superbugs – carbapenem antibiotics – is succumbing to the deadly bacteria.
An overview of malaria research and progress to date, including vaccine and drug development, and our research in malaria-endemic countries.
Our research has revealed an unanticipated secret about the cells that form the first line of defence in the body’s fight against infection